- Home
- PLRX vs GRAL Comparison
PLRX vs GRAL Comparison
Compare PLRX & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- GRAL
- Stock Information
- Founded
- PLRX 2015
- GRAL 2016
- Country
- PLRX United States
- GRAL United States
- Employees
- PLRX N/A
- GRAL N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- GRAL
- Sector
- PLRX Health Care
- GRAL
- Exchange
- PLRX Nasdaq
- GRAL NYSE
- Market Cap
- PLRX 682.2M
- GRAL 610.9M
- IPO Year
- PLRX 2020
- GRAL N/A
- Fundamental
- Price
- PLRX $10.92
- GRAL $28.61
- Analyst Decision
- PLRX Strong Buy
- GRAL Hold
- Analyst Count
- PLRX 7
- GRAL 2
- Target Price
- PLRX $40.50
- GRAL $16.00
- AVG Volume (30 Days)
- PLRX 454.1K
- GRAL 893.1K
- Earning Date
- PLRX 02-26-2025
- GRAL 02-15-2025
- Dividend Yield
- PLRX N/A
- GRAL N/A
- EPS Growth
- PLRX N/A
- GRAL N/A
- EPS
- PLRX N/A
- GRAL N/A
- Revenue
- PLRX N/A
- GRAL $117,669,000.00
- Revenue This Year
- PLRX N/A
- GRAL $32.48
- Revenue Next Year
- PLRX N/A
- GRAL $14.72
- P/E Ratio
- PLRX N/A
- GRAL N/A
- Revenue Growth
- PLRX N/A
- GRAL 111.83
- 52 Week Low
- PLRX $10.22
- GRAL $12.33
- 52 Week High
- PLRX $18.92
- GRAL $29.79
- Technical
- Relative Strength Index (RSI)
- PLRX 36.45
- GRAL N/A
- Support Level
- PLRX $10.68
- GRAL N/A
- Resistance Level
- PLRX $11.40
- GRAL N/A
- Average True Range (ATR)
- PLRX 0.71
- GRAL 0.00
- MACD
- PLRX -0.14
- GRAL 0.00
- Stochastic Oscillator
- PLRX 7.92
- GRAL 0.00
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.